Trial Profile
Phase II randomised trial of first-line lenalidomide administered before or after conventional chemotherapy in patients with acute myeloid leukaemia.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2013
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 05 Feb 2013 New trial record